<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K3L4M3" height="0" width="0" style="display:none;visibility:hidden">

Flat White

Why should we rely on mRNA vaccines?

9 July 2021

4:00 AM

9 July 2021

4:00 AM

Last month the federal government announced that the AstraZeneca vaccine would be phased out, with it being available only ‘on request’ after October of this year. This decision followed numerous blood clotting cases and some deaths occurring following vaccination.  

The government will now rely on the Pfizer and Moderna vaccines. However, these mRNA inoculations are not without their problems, either.

Already a subscriber? Log in

Subscribe for just $2 a week

Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.

  • Unlimited access to spectator.com.au and app
  • The weekly edition on the Spectator Australia app
  • Spectator podcasts and newsletters
  • Full access to spectator.co.uk

Unlock this article



Don't miss out

Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.

Already a subscriber? Log in